These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8075942)

  • 21. Recent developments in research of HIV infection--a "state of art" (a review).
    Füst G
    Acta Microbiol Immunol Hung; 1994; 41(1):5-21. PubMed ID: 7921851
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 step study.
    White AM
    Lancet; 2009 Mar; 373(9666):805; author reply 806. PubMed ID: 19269505
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of immune responses during HIV-malaria co-infection in pregnancy.
    Ned RM; Moore JM; Chaisavaneeyakorn S; Udhayakumar V
    Trends Parasitol; 2005 Jun; 21(6):284-91. PubMed ID: 15922250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["Kroly Than" Pharmacy, Sopron, Hungary].
    Reisner E
    Acta Pharm Hung; 2001 Oct; 71(3):367-71. PubMed ID: 11961907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV superinfection in women may boost immune response.
    Rose S
    Expert Rev Anti Infect Ther; 2012 May; 10(5):525. PubMed ID: 22702314
    [No Abstract]   [Full Text] [Related]  

  • 26. Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.
    Kekow J; Wachsman W; McCutchan JA; Gross WL; Zachariah M; Carson DA; Lotz M
    J Clin Invest; 1991 Mar; 87(3):1010-6. PubMed ID: 1999481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of natural and vaccine immunity against HIV.
    Keane N; John M
    Biomark Med; 2011 Apr; 5(2):113-6. PubMed ID: 21473715
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and laboratory characteristics of HIV-infection in servicemen].
    Volzhanin VM; Zigalenko DG; Bolekhan VN; Bulan'kov IuI; Chabanenko AI
    Voen Med Zh; 2005 Jan; 326(1):47-52, 80. PubMed ID: 15754771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.
    Buechler MB; Newman LP; Chohan BH; Njoroge A; Wamalwa D; Farquhar C
    Clin Exp Immunol; 2015 Sep; 181(3):451-6. PubMed ID: 25739813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal immunity to HIV--natural infection, vaccination, or both?
    Fauci AS
    N Engl J Med; 1991 Jun; 324(24):1733-5. PubMed ID: 2034251
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
    Richman DD; Wrin T; Little SJ; Petropoulos CJ
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4144-9. PubMed ID: 12644702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study on some systemic humoral and cellular immune markers in only HIV or HIV and hepatitis B infected children.
    Voiculescu C; Bălăşoiu M; Turculeanu A; Filipaş L; Voiculescu M; Georgescu D
    Rom J Virol; 1993; 44(1-2):97-111. PubMed ID: 9702255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H. influenzae vaccines in HIV.
    Ranki A; Leinikki P; Krohn K; Sarna S; Valle SL
    N Engl J Med; 1992 Jun; 326(23):1569-70; author reply 1570-1. PubMed ID: 1579148
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.
    Marcelino JM; Nilsson C; Barroso H; Gomes P; Borrego P; Maltez F; Rosado L; Doroana M; Antunes F; Taveira N
    AIDS; 2008 Nov; 22(17):2257-65. PubMed ID: 18981765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    Gagneux-Brunon A; Rochereau N; Botelho-Nevers E; Lucht F; Pozzetto B; Paul S; Bourlet T
    AIDS; 2017 May; 31(8):1055-1064. PubMed ID: 28323750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
    Chuenchitra T; Wasi C; Louisirirojchanakul S; Nitayaphan S; Sutthent R; Cox JH; De Souza MS; Brown AE; Birx DL; Polonis VR
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):293-305. PubMed ID: 12804005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.
    Rinaldi S; Zangari P; Cotugno N; Manno EC; Brolatti N; Castrucci MR; Donatelli I; Rossi P; Palma P; Cagigi A
    Vaccine; 2014 Feb; 32(6):657-63. PubMed ID: 24333344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal HIV infection and antibody responses in uninfected infants.
    de Souza TL; Fernandes RC; Medina-Acosta E
    JAMA; 2011 May; 305(19):1964; author reply 1964-5. PubMed ID: 21586709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.